INNOVIVA, INC. Dividends Payable, Amount Per Share
INNOVIVA, INC. (INVA) had Dividends Payable, Amount Per Share of $0.25 per share as of 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:DividendsPayableAmountPerShare · last filed 2015-05-08
- 2015-03-31: Dividends Payable, Amount Per Share $0.25.
- 2014-10-16: Dividends Payable, Amount Per Share $0.25.
- 2014-09-30: Dividends Payable, Amount Per Share $0.25.
- 2014-07-25: Dividends Payable, Amount Per Share $0.25.
| Period end | Dividends Payable, Amount Per Share |
|---|---|
| 2015-03-31 | $0.25 10-Q · filed 2015-05-08 |
| 2014-10-16 | $0.25 10-Q · filed 2014-11-04 |
| 2014-09-30 | $0.25 10-Q · filed 2014-11-04 |
| 2014-07-25 | $0.25 10-Q · filed 2014-11-04 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-08 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |